Moderna (MRNA) Stock Price Might Drop to $100 After Earnings
- bhoomisinghal0
- Aug 2, 2023
- 1 min read
Moderna Inc. will report Q2 earnings on August 3, 2023, with MRNA stock currently down by 3.16%. On July 31, 2023, Cathie Wood’s Ark Invest sold around 64,800 shares of EV maker BYD Co. Ltd. and purchased 61,741 Moderna stocks. A leader in mRNA technology, The Genomic Revolution ETF also bought 61,741 Moderna Shares worth $7.6 Million. Last week, Moderna Inc. agreed with the Chinese government to research and develop mRNA medicines in the country. MRNA stock, at press time, is trading at $113.94 with a drop of 3.16%; previous close and open were at $117.66 and $117.00, respectively. The 52-week range is from $113.77 to $217.25, indicating that a slight push could make new lows.
Check out the hashd app. It gives you important crypto news and updates in short, simple and easy to read slides. Amazing!
Android: https://links.hashd.co/android
Comments